| Literature DB >> 30770246 |
Renée R C E Schreurs1, Martin E Baumdick2, Adrian F Sagebiel2, Max Kaufmann3, Michal Mokry4, Paul L Klarenbeek5, Nicola Schaltenberg6, Fenja L Steinert2, Jorik M van Rijn4, Agata Drewniak7, Sarah-May M L The8, Roel Bakx9, Joep P M Derikx9, Niek de Vries5, Willemijn E Corpeleijn10, Steven T Pals11, Nicola Gagliani12, Manuel A Friese3, Sabine Middendorp4, Edward E S Nieuwenhuis4, Konrad Reinshagen13, Teunis B H Geijtenbeek14, Johannes B van Goudoever15, Madeleine J Bunders16.
Abstract
Although the fetal immune system is considered tolerogenic, preterm infants can suffer from severe intestinal inflammation, including necrotizing enterocolitis (NEC). Here, we demonstrate that human fetal intestines predominantly contain tumor necrosis factor-α (TNF-α)+CD4+CD69+ T effector memory (Tem) cells. Single-cell RNA sequencing of fetal intestinal CD4+ T cells showed a T helper 1 phenotype and expression of genes mediating epithelial growth and cell cycling. Organoid co-cultures revealed a dose-dependent, TNF-α-mediated effect of fetal intestinal CD4+ T cells on intestinal stem cell (ISC) development, in which low T cell numbers supported epithelial development, whereas high numbers abrogated ISC proliferation. CD4+ Tem cell frequencies were higher in inflamed intestines from preterm infants with NEC than in healthy infant intestines and showed enhanced TNF signaling. These findings reveal a distinct population of TNF-α-producing CD4+ T cells that promote mucosal development in fetal intestines but can also mediate inflammation upon preterm birth.Entities:
Keywords: CD4(+) T cells; TNF-α; immune ontogeny; intestinal mucosa; intestinal stem cells; organoid technology; stem cell biology; tissue generation
Mesh:
Substances:
Year: 2019 PMID: 30770246 DOI: 10.1016/j.immuni.2018.12.010
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745